Skip to main content

Hypertension

  • Reference work entry
  • First Online:
Geriatric Medicine

Abstract

Hypertension is very common in older adults and causes significant morbidity and mortality. Treatment is very effective at reducing stroke, cardiac events, and mortality, even in the very old. Hypertension is defined as a systolic blood pressure > 130 mmHg or a diastolic blood pressure > 80 mmHg. Due to changes in physiology, comorbid conditions, increased susceptibility to side effects, and socioeconomic factors, blood pressure goals and treatments must be individualized for each older adult. The blood pressure goal in robust patients is systolic blood pressure < 130 mmHg. Nursing home residents and patients with advanced frailty or advanced cognitive decline likely need higher goals. Nonpharmacologic therapy should be implemented in all patients. First-line antihypertensive agents are angiotensin-converting enzyme inhibitors, non-dihydropyridine calcium channel blockers, thiazide diuretics, and angiotensin II receptor blockers. Comorbid conditions may influence choice of agents. Therapy requires close monitoring for potentially serious side effects, including electrolyte abnormalities, renal function, and orthostatic hypotension. Deprescribing should regularly be considered as cognition declines, frailty increases, or there are serious side effects from treatment. Involving caregivers in the education and management of hypertension is often essential due to frailty and/or cognitive decline. Use of an interprofessional team and telehealth for monitoring can be very helpful in the longitudinal care of older adults with hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71(19):e127–248.

    Article  PubMed  Google Scholar 

  2. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics – 2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56–e528.

    Article  PubMed  Google Scholar 

  3. Agarwala A, Mehta A, Yang E, Parapid B. Older adults and hypertension: beyond the 2017 guideline for prevention, detection, evaluation, and management of high blood pressure in adults, American College of Cardiology. 2020. Access online on 20 Aug 2020: https://www.acc.org/latest-in-cardiology/articles/2020/02/26/06/24/older-adults-and-hypertension.

  4. Kotliar C, et al. Improved identification of secondary hypertension: use of a systematic protocol. Ann Transl Med. 2018;6(15):293–302.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ 1992;304:405–12. [PMID: 1445513].

    Google Scholar 

  6. SHEP Cooperative Research Group. Prevention of stroke by anitihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA. 1991;265:3255–64.

    Article  Google Scholar 

  7. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887–98.

    Article  CAS  PubMed  Google Scholar 

  8. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, et al. Randomized double-blind comparison of placebo and active treatment of older patients with isolated systolic hypertension. Lancet. 1997;350:757–64.

    Article  CAS  PubMed  Google Scholar 

  9. Wright JT, Williamson JD, Whelton PK, et al. SPRINT Reseach Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2013–116.

    Google Scholar 

  10. Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized controlled trial. JAMA. 2016;315(24):2673–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Weiss J, Freeman M, Low A, Fu R, Kerfoot A, Paynter R, et al. Benefits and harms of intensive blood pressure treatment in adults aged 60 years or older. A systematic review and meta-analysis. Ann Int Med. 2017;166:419–29.

    Article  PubMed  Google Scholar 

  12. McGuinness B, Todd S, Passmore P, Bullock R. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev. 2009;4:CD004034.

    Google Scholar 

  13. The SPRINT MIND Investigators. Effect of intensive vs standard blood pressure control on probable dementia. JAMA. 2019;321(6):553–61.

    Article  Google Scholar 

  14. Benetos A, Petorvic M, Strandberg T. Hypertension management in older and Frail older patients. Circ Res. 2019;124:1045–60.

    Article  CAS  PubMed  Google Scholar 

  15. Rich MW, Ouslander JG. Hypertension in older adults in the wake of the systolic blood pressure intervention trial. JAGS. 2018;66:652–4.

    Article  Google Scholar 

  16. Qaseem A, Wilt TJ, Rich R, Humphrey LL, Frost J, Forciea MA, Clinical Guidelines Committee of the American College of Physicians and the Commission on Health of the Public and Science of the American Academy of Family Physicians. Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Int Med. 2017;166:430–7.

    Article  PubMed  Google Scholar 

  17. Williams B, Mancia G, Spiering W, Rosei E, Azizi M, Burnier M, Clement D, Coca A, Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen S, Kreutz R, Laurent S. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104.

    Article  PubMed  Google Scholar 

  18. ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575–85.

    Article  Google Scholar 

  19. Mader SL. Identification and management of orthostatic hypotension in older and medically complex patients. Expert Rev Cardiovasc Ther. 2012;10(3):387–95.

    Article  CAS  PubMed  Google Scholar 

  20. Benetos A, Labat C, Rossignol P, et al. Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents. The PARTAGE study. JAMA Int Med. 2015;175(6):989–95.

    Article  Google Scholar 

  21. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336:1117–24.

    Article  CAS  PubMed  Google Scholar 

  22. Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr, Kostis JB, Kumanyika S, Lacy CR, Johnson KC, Folmar S, Cutler JA. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA. 1998;279(11):839–46.

    Article  CAS  PubMed  Google Scholar 

  23. The ALLHAT OFFICERS. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic. JAMA. 2002;288:2981–97.

    Article  Google Scholar 

  24. Jamerson K, Weber MA, Bakris GL, Dahhlof B, Pitt B, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417–28.

    Article  CAS  PubMed  Google Scholar 

  25. Patel KK, Young L, Howell EH, et al. Characteristics and outcomes of patients presenting with hypertensive urgency in the office setting. JAMA Intern Med. 2016;176(7):981–8.

    Article  PubMed  Google Scholar 

  26. Katz JN, Gore JM, Amin A, Anderson FA, Dasta JF, Ferguson JJ, Kleinschmidt K, Mayer SA, Multz AS, Peacock F, Peterson E, Pollack C, Sung GY, Shorr A, Varon J, Wyman A, et al. Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) Registry. Am Heart J. 2009;153(4):599–606.

    Article  Google Scholar 

  27. Khatib R, Schwalm J-D, Yusuf S, Haynes RB, McKee M, Khan M, et al. Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies. PLoS One. 2014;9(1):e84238.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Craig R. Keenan .

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2024 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Landefeld, J.C., Jain, S., Keenan, C.R. (2024). Hypertension. In: Wasserman, M.R., Bakerjian, D., Linnebur, S., Brangman, S., Cesari, M., Rosen, S. (eds) Geriatric Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-74720-6_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-74720-6_26

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-74719-0

  • Online ISBN: 978-3-030-74720-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics